Target intelligence / Profile preview

Clostridioides difficile surface receptors

Molecular classification
Bacterial surface protein, Adhesin, Receptor, S-layer protein
01

Overview

Clostridioides difficile surface receptors (formerly Clostridium difficile) refer to a group of proteins that facilitate the bacterium's colonization and the subsequent entry of its potent toxins into host cells. The primary bacterial surface components are the surface layer proteins (SLPs), most notably SlpA, which form a paracrystalline array that mediates adhesion to the intestinal mucosa and provides a scaffold for other cell wall proteins (Cwps) like Cwp66 and FbpA (Kirk et al., 2017, PubMed: 29153330). On the host side, C. difficile toxins TcdA and TcdB exploit specific cell surface receptors to trigger endocytosis. TcdB binds to Frizzled proteins (FZD1, 2, and 7), Chondroitin Sulfate Proteoglycan 4 (CSPG4), and Poliovirus Receptor-Related 3 (PVRL3) (Tao et al., 2016, PubMed: 27657135). TcdA utilizes receptors such as glycoprotein 96 (gp96) and sucrase-isomaltase (Yuan et al., 2015, PubMed: 25938225). These interactions are critical for the development of C. difficile infection (CDI), which is characterized by severe diarrhea and pseudomembranous colitis. Therapeutic strategies targeting these receptors include the monoclonal antibody Bezlotoxumab, which prevents TcdB from binding to host receptors (Wilcox et al., 2017, PubMed: 28121507). Experimental vaccines like VLA84 target bacterial SLPs to inhibit colonization and provide a narrow-spectrum approach to treatment.

Other names
Clostridium difficile surface receptorsC. diff surface proteinsS-layer proteinsSlpACell wall proteins (Cwps)Host toxin receptorsTcdB receptorsTcdA receptors
02

Mechanism of action

Neutralization of toxin-receptor binding; Inhibition of bacterial adhesion to intestinal epithelium; Induction of mucosal immunity against surface antigens.

03

Biological functions

Cell adhesionBacterial colonizationToxin-mediated endocytosisImmune evasionBiofilm formation
04

Disease associations

InfectionPseudomembranous colitisAntibiotic-associated diarrhea
05

Safety considerations

Potential for off-target effects on host Wnt signaling (if targeting Frizzled receptors)Risk of immunogenicity with vaccine candidatesDisruption of commensal gut microbiota with non-specific agents
06

Interacting drugs

Bezlotoxumab

2 more in the full profile.

07

Biomarkers

Clostridioides difficile toxin AClostridioides difficile toxin BGlutamate dehydrogenase (GDH)

Beyond the preview

Go deeper on Clostridioides difficile surface receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clostridioides difficile surface receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call